Segui
Kristin L Bigos
Kristin L Bigos
Johns Hopkins School of Medicine
Email verificata su jhu.edu - Home page
Titolo
Citata da
Citata da
Anno
Genetic variation in CACNA1C affects brain circuitries related to mental illness
KL Bigos, VS Mattay, JH Callicott, RE Straub, R Vakkalanka, B Kolachana, ...
Archives of general psychiatry 67 (9), 939-945, 2010
3752010
Principles of gender-specific medicine
MJ Legato, JP Bilezikian
Gulf Professional Publishing, 2004
2932004
Sex, race, and smoking impact olanzapine exposure
KL Bigos, BG Pollock, KC Coley, DD Miller, SR Marder, M Aravagiri, ...
The Journal of Clinical Pharmacology 48 (2), 157-165, 2008
2232008
Acute 5-HT reuptake blockade potentiates human amygdala reactivity
KL Bigos, BG Pollock, HJ Aizenstein, PM Fisher, RR Bies, AR Hariri
Neuropsychopharmacology 33 (13), 3221-3225, 2008
1822008
Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review
KL Bigos, BG Pollock, BA Stankevich, RR Bies
Gender medicine 6 (4), 522-543, 2009
1792009
Imaging genetics—days of future past
KL Bigos, DR Weinberger
Neuroimage 53 (3), 804-809, 2010
1722010
Suboptimal aminoglycoside dosing in critically ill patients
RS Rea, B Capitano, R Bies, KL Bigos, R Smith, H Lee
Therapeutic drug monitoring 30 (6), 674-681, 2008
1672008
Genetic variation in CYP3A43 explains racial difference in olanzapine clearance
KL Bigos, RR Bies, BG Pollock, JJ Lowy, F Zhang, DR Weinberger
Molecular psychiatry 16 (6), 620-625, 2011
902011
Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophrenia
JA Apud, F Zhang, H Decot, KL Bigos, DR Weinberger
American Journal of Psychiatry 169 (7), 725-734, 2012
662012
The influence of hormones and pharmaceutical agents on DHEA and DHEA‐S concentrations: a review of clinical studies
FS Salek, KL Bigos, PD Kroboth
The Journal of Clinical Pharmacology 42 (3), 247-266, 2002
592002
Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals
D Dickinson, RE Straub, JW Trampush, Y Gao, N Feng, B Xie, JH Shin, ...
JAMA psychiatry 71 (6), 647-656, 2014
542014
Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants.
RR Bies, KL Bigos, BG Pollock
The journal of gender-specific medicine: JGSM: the official journal of the …, 2003
542003
Neuroimaging genetics: principles and practices
KL Bigos, AR Hariri, DR Weinberger
Oxford University Press, 2016
522016
Influence of DHEA administration on 24-hour cortisol concentrations
PD Kroboth, JA Amico, RA Stone, M Folan, RF Frye, FJ Kroboth, KL Bigos, ...
Journal of clinical psychopharmacology 23 (1), 96-99, 2003
512003
Association of missense mutation in FOLH1 with decreased NAAG levels and impaired working memory circuitry and cognition
CF Zink, PB Barker, A Sawa, DR Weinberger, M Wang, H Quillian, ...
American Journal of Psychiatry 177 (12), 1129-1139, 2020
402020
Dysregulation of neurosteroids in obsessive compulsive disorder
KL Bigos, MM Folan, MR Jones, GL Haas, FJ Kroboth, PD Kroboth
Journal of psychiatric research 43 (4), 442-445, 2009
402009
Population pharmacokinetics in geriatric psychiatry
KL Bigos, RR Bies, BG Pollock
The American journal of geriatric psychiatry 14 (12), 993-1003, 2006
402006
Neuroimaging: technologies at the interface of genes, brain, and behavior
KL Bigos, AR Hariri
Neuroimaging Clinics of North America 17 (4), 459-467, 2007
302007
Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status
J Heide, F Zhang, KL Bigos, SA Mann, VJ Carr, C Shannon Weickert, ...
American Journal of Psychiatry 173 (1), 53-59, 2016
272016
Nimodipine improves cortical efficiency during working memory in healthy subjects
CF Zink, M Giegerich, GE Prettyman, KE Carta, M van Ginkel, ...
Translational psychiatry 10 (1), 372, 2020
202020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20